SCHEMBL3872595

SCHEMBL3872595

CC(C)(C)c1cc(O)c(O)c(O)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.57
GABRB2 P47870 1/20 0.57
ALDH1A1 P00352 5/20 0.56
ALOX15 P16050 3/20 0.56
HPGD P15428 2/20 0.56
HSD17B10 Q99714 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
SELL P14151 1/20 0.48
SELP P16109 1/20 0.48
SELE P16581 1/20 0.48
CYP2C19 P33261 2/20 0.46
MAPT P10636 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
CYP1A2 P05177 2/20 0.46
KDM4E B2RXH2 1/20 0.46
ATP2A2 P16615 1/20 0.46
ATP2A3 Q93084 1/20 0.46
RECQL P46063 2/20 0.44
MEN1 O00255 1/20 0.44
GAA P10253 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methane SCHEMBL27627234 0.97 GABRA1 (0.55) GABRA1GABRB2ALDH1A1ALOX15HPGD
SCHEMBL16256478 0.87 ALDH1A1 (0.50) GABRA1GABRB2ALDH1A1ALOX15HPGD
SCHEMBL931756 0.87 ALDH1A1 (0.50) GABRA1GABRB2ALDH1A1ALOX15HPGD
SCHEMBL29416834 0.85 CA2 (0.52) GABRA1GABRB2ALDH1A1ALOX15HPGD
SCHEMBL247483 0.85 CA2 (0.52) GABRA1GABRB2ALDH1A1ALOX15HPGD
SCHEMBL23079300 0.85 ALDH1A1 (0.48) GABRA1GABRB2ALDH1A1ALOX15HPGD
SCHEMBL23542361 0.83 ALDH1A1 (0.46) GABRA1GABRB2ALDH1A1ALOX15HPGD
SCHEMBL30718926 0.83 CA2 (0.50) GABRA1GABRB2ALDH1A1ALOX15HPGD
SCHEMBL68929 0.83 ALOX15 (0.58) GABRA1GABRB2ALDH1A1ALOX15HPGD
SCHEMBL28135995 0.83 CA2 (0.50) GABRA1GABRB2ALDH1A1ALOX15HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 212 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12595369-B2 Algae-resistant bitumen-containing materials ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2026-04-07 US claimed
EP-4088757-B1 PHENOL DERIVATIVE-FUNCTIONALIZED CHONDROITIN SULFATE HYDROGEL AND USE OF SAME CELLARTGEN INC (KR) 2025-12-10 EP claimed
CN-114072132-B Bionic tissue adhesive hydrogel patch and application thereof 赛拉尔研究有限公司 2024-11-15 CN claimed
US-20240367148-A1 BIO-GRAFTED SILICA AS AN ADSORBENT OF VOLATILE ORGANIC COMPOUNDS ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2024-11-07 US claimed
WO-2024191143-A1 MULTI-METAL NANOCOMPOSITES 최종훈 2024-09-19 WO claimed
US-20240026039-A1 PECTIN MODIFIED WITH GALLOL DERIVATIVE AND USE THEREOF UIF (UNIVERSITY INDUSTRY FOUNDATION), YONSEI UNIVERSITY (KR) 2024-01-25 US claimed
EP-4299598-A1 PECTIN MODIFIED WITH GALLOL DERIVATIVE AND USE THEREOF University-Industry Foundation(UIF), Yonsei University (KR) 2024-01-03 EP claimed
CN-117120481-A Pectin modified by gallic acid derivative and its use UIF延世大学校产学协力团 2023-11-24 CN claimed
US-20230355518-A1 DECELLULARIZED TISSUE-DERIVED EXTRACELLULAR MATRIX FUNCTIONALIZED WITH PHENOL DERIVATIVE AND USE THEREOF Cellartgen Inc. (KR) 2023-11-09 US claimed
EP-4265714-A1 DECELLULARIZED TISSUE-DERIVED EXTRACELLULAR MATRIX MODIFIED WITH PHENOL DERIVATIVE AND USE THEREOF Cellartgen Inc. (KR) 2023-10-25 EP claimed
EP-3981393-A1 BIOMIMETIC TISSUE-ADHESIVE HYDROGEL PATCH AND USE THEREOF Cellartgen Inc. (KR) 2022-04-13 EP claimed
WO-2022050695-A1 EXTRACELLULAR MATRIX-SUPPORTED BIOMIMETIC TISSUE ADHESIVE HYDROGEL PATCH 주식회사 세라트젠 2022-03-10 WO claimed
WO-2022050682-A1 EXOSOMES-LOADED BIOMIMETIC TISSUE-ADHESIVE HYDROGEL PATCH 주식회사 세라트젠 2022-03-10 WO claimed
WO-2022050694-A1 BIOMIMETIC TISSUE-ADHESIVE HYDROGEL PATCH FOR PREVENTING OR TREATING CARTILAGE OR BONE DISEASES 주식회사 세라트젠 2022-03-10 WO claimed
CN-114072132-A Bionic tissue adhesive hydrogel patch and application thereof 赛拉尔研究有限公司 2022-02-18 CN claimed
CN-107245376-B Litchi wood smoking spice and preparation method thereof 广州城市职业学院 2021-02-05 CN claimed
WO-2021006426-A1 BIOMIMETIC TISSUE-ADHESIVE HYDROGEL PATCH AND USE THEREOF 연세대학교 산학협력단 2021-01-14 WO claimed
US-20210007352-A1 SYNTHESIS AND FORMULATION OF LIGNIN DERIVED COMPOUNDS AS TREATMENT OF PLANT DISEASES UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2021-01-14 US claimed
CN-105527803-B Photoresist cleaning solution 安集微电子(上海)有限公司 2020-08-18 CN claimed
US-5780515-A APPLYING TO PLANTS; REDUCED TOXICITY AND IRRITATION ROCKHURST UNIVERSITY (US) 1998-07-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240026039-A1 PECTIN MODIFIED WITH GALLOL DERIVATIVE AND USE THEREOF CD69, CD4, CD44 GABRA1 2594/4885GABRB2 1784/4885ALDH1A1 2340/4885
US-12595369-B2 Algae-resistant bitumen-containing materials BECN1, SFN, DEK GABRA1 2664/4885GABRB2 1420/4885ALDH1A1 2833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.